MiR-107 has been reported to be downregulated in acute promyelocytic leukemia (APL) blasts as compared with normal promyelocytes differentiated in vitro from CD34+ progenitors, and its expression level was upregulated after cells had been treated with ATRA [82]. This evidence concerns the gene CD34 and acute promyelocytic leukemia.